One of the most common questions in the telehealth weight loss space is about compounded GLP-1 medications. Compounded semaglutide and tirzepatide have been widely prescribed through telehealth programs at significantly lower cost than brand-name alternatives. But what exactly is compounding, how does it differ from brand-name drugs, and what does it mean for your treatment?
What Are Brand-Name GLP-1 Medications
Brand-name GLP-1 medications for weight loss include:
- Wegovy (semaglutide 2.4mg, Novo Nordisk) — FDA-approved for chronic weight management
- Ozempic (semaglutide 0.5–2mg, Novo Nordisk) — FDA-approved for type 2 diabetes, widely prescribed off-label for weight loss
- Zepbound (tirzepatide 2.5–15mg, Eli Lilly) — FDA-approved for chronic weight management
- Mounjaro (tirzepatide, Eli Lilly) — FDA-approved for type 2 diabetes
Brand-name medications undergo rigorous FDA review for safety, efficacy, manufacturing quality, and labeling. They are produced in tightly controlled pharmaceutical manufacturing facilities.
What Is Compounded GLP-1
Compounded GLP-1 refers to semaglutide or tirzepatide prepared by a licensed 503A or 503B compounding pharmacy using active pharmaceutical ingredients (APIs). The compound is not the finished drug product itself but is prepared from pharmaceutical-grade ingredients.
Key points about compounded GLP-1:
- Compounded formulations are not FDA-approved as finished drugs
- Quality, potency, and sterility depend on the specific pharmacy and its practices
- Compounding is legal when the brand-name product is on the FDA drug shortage list (this has been a key factor in GLP-1 compounding availability)
- 503B outsourcing facilities face stricter federal oversight than traditional 503A pharmacies
- Reputable programs source from FDA-registered, PCAB-accredited pharmacies with third-party testing
Side-by-Side Comparison
| Factor | Brand-Name GLP-1 | Compounded GLP-1 |
|---|---|---|
| FDA Approval | Yes (finished drug product) | No (preparation from API) |
| Manufacturing Standards | FDA GMP requirements | Pharmacy-specific; varies |
| Cost | $800–$1,600+/month (without insurance) | $150–$500/month (typical range) |
| Insurance Coverage | Some plans; highly variable | Generally not covered |
| Dosing Flexibility | Fixed standard doses | Customizable by clinician |
| Clinical Evidence Base | Extensive trial data | Based on same API; no separate trials |
How to Evaluate a Compounding Pharmacy
Not all compounding pharmacies operate at the same standard. When evaluating a telehealth program that uses compounded GLP-1, ask:
- Is the pharmacy FDA-registered and state-licensed?
- Is it a 503B outsourcing facility (stricter federal oversight) or 503A pharmacy?
- Is PCAB accreditation held?
- Are third-party potency and sterility certificates available?
- What is the storage and stability protocol for the compounded product?
The Regulatory Landscape
GLP-1 compounding has operated in a changing regulatory environment. The FDA permits compounding of drugs on the official shortage list. Shortage status for semaglutide and tirzepatide has fluctuated, and FDA enforcement actions against compounders have increased when shortage determinations change. Any telehealth program offering compounded GLP-1 should be monitoring and communicating the current regulatory status with enrolled patients.
Frequently Asked Questions
Is compounded semaglutide the same as Wegovy?
It uses the same active ingredient but is not manufactured by the same process or under the same FDA oversight. Quality depends heavily on the pharmacy source.
Is compounded GLP-1 safe?
From reputable, FDA-registered pharmacies with third-party testing, it is generally considered appropriate for clinical use. FDA has flagged some lower-quality compounders for quality control failures — pharmacy source matters significantly.
Why is compounded GLP-1 so much cheaper?
Brand-name pricing reflects the cost of the original clinical development, FDA approval process, and pharmaceutical-scale manufacturing. Compounding pharmacies produce smaller batches at lower overhead without those development costs.
What happens if compounding becomes illegal?
If the drug shortage designation is removed, compounding restrictions may tighten. Patients would need to transition to brand-name products. Reputable programs communicate these changes proactively.
Find a Program With Transparent Pharmacy Standards
The best telehealth programs disclose their pharmacy source, accreditation status, and regulatory compliance clearly. Our comparison highlights programs with transparent quality practices.
Compare Weight Loss Programs →